Acorda CEO Cohen on U.S. Budget Cuts, Research

March 22 (Bloomberg) -- Ron Cohen, chief executive officer of Acorda Therapeutics Inc., talks about the impact of U.S. budget cuts on medical research and drug development. Cohen, speaking with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance," also discusses China's investment in medical care and science. (Source: Bloomberg)

Canadian National Beats Estimates After Cutting Costs
44:20 - Canadian National Railway reported second-quarter profit that topped analysts’ estimates as the carrier cut jobs and parked locomotives to blunt the effects of weakening freight demand. Bloomberg Intelligence's Lee Klaskow speaks on The Daily Brief. (Source: Bloomberg)
  • Solar Impulse 2 Completes Global Epic Journey
  • Southeast Asian Nations Divided on South China Sea
  • Full Show: Bloomberg West (07/25)